Sight Sciences

Healthcare

Connections 1

Subscribe To favorites

Description

Sight Sciences, Inc. is an ophthalmic medical device company.

The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company’s surgical glaucoma product portfolio features the OMNI surgical system (OMNI), a device that facilitates the performance of both trabeculotomy and canaloplasty with a single device and single corneal incision. Its nonsurgical dry eye product portfolio consists of the TearCare system for ophthalmologists and optometrists.

TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids. The Company has two reportable segments: Surgical Glaucoma and Dry Eye. Its Surgical Glaucoma segment consists of sales of the OMNI surgical system. Its Dry Eye segment includes sales of the TearCare system and related components and accessories. The Company primarily sell both the systems through a direct sales model.

Website

https://www.sightsciences.com

Rating GlobalNY.biz

Take place №4093 In rating New York Organizations general
Take place №412 In rating Healthcare area

<!-- advertisement 10-->
<div class="mobileShow">
<script>
  atOptions = {
    'key' : '33fb986b72fdc254fb0c1e79be22e3ec',
    'format' : 'iframe',
    'height' : 250,
    'width' : 300,
    'params' : {}
  };
</script>
<script src="https://www.highperformanceformat.com/33fb986b72fdc254fb0c1e79be22e3ec/invoke.js"></script>
</div>
<div class="mobileHide">
<script>
  atOptions = {
    'key' : '60966449084d21264769e3d9bdff986a',
    'format' : 'iframe',
    'height' : 90,
    'width' : 728,
    'params' : {}
  };
</script>
<script src="https://www.highperformanceformat.com/60966449084d21264769e3d9bdff986a/invoke.js"></script>
</div>

21 March 2022

Business

Important things to watch this week: Company reports and economic events

Schedule for the week US stock indices rose on Friday, ending the week with the biggest gain since ...

<!-- advertisement 12-->
<div class="mobileShow">
<script type="text/javascript">
	atOptions = {
		'key' : '33fb986b72fdc254fb0c1e79be22e3ec',
		'format' : 'iframe',
		'height' : 250,
		'width' : 300,
		'params' : {}
	};
</script>
<script type="text/javascript" src="//www.highperformanceformat.com/33fb986b72fdc254fb0c1e79be22e3ec/invoke.js"></script>
</div>
<div class="mobileHide">
<script type="text/javascript">
	atOptions = {
		'key' : '60966449084d21264769e3d9bdff986a',
		'format' : 'iframe',
		'height' : 90,
		'width' : 728,
		'params' : {}
	};
</script>
<script type="text/javascript" src="//www.highperformanceformat.com/60966449084d21264769e3d9bdff986a/invoke.js"></script>
</div>

MALKOVICH John

I am humbled to be chosen for this award, which has been given to so many wonderful actors over the past 83 iterations of the Venice Film Festival

KIMMEL James

This is yet another attack on free speech, something that has become all too familiar for us at the show, for us in the country

COMPSTON Martin

It's for Jed to say, it's not for me to say whether the show will ever end but I think it's fair to say that this is the end of the story arc that's been building since series one. Everything will come to a head on this one.